Concepedia

Publication | Closed Access

Expression of bcl-2-, p53, and Ki-67 and outcome of patients with primary nasopharyngeal carcinomas following DNA-damaging treatment

28

Citations

31

References

1998

Year

Abstract

The enhanced expression of p53 may be a prognostic factor in patients with NPCs whose tumor is resistant to therapy that damages DNA.

References

YearCitations

Page 1